Zimmer Biomet Holdings Inc
NYSE:ZBH

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
NYSE:ZBH
Watchlist
Price: 108.41 USD 1.06% Market Closed
Market Cap: 22.1B USD
Have any thoughts about
Zimmer Biomet Holdings Inc?
Write Note

Intrinsic Value

The intrinsic value of one ZBH stock under the Base Case scenario is 152.24 USD. Compared to the current market price of 108.41 USD, Zimmer Biomet Holdings Inc is Undervalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ZBH Intrinsic Value
152.24 USD
Undervaluation 29%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Zimmer Biomet Holdings Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ZBH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ZBH?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Zimmer Biomet Holdings Inc

Provide an overview of the primary business activities
of Zimmer Biomet Holdings Inc.

What unique competitive advantages
does Zimmer Biomet Holdings Inc hold over its rivals?

What risks and challenges
does Zimmer Biomet Holdings Inc face in the near future?

Has there been any significant insider trading activity
in Zimmer Biomet Holdings Inc recently?

Summarize the latest earnings call
of Zimmer Biomet Holdings Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Zimmer Biomet Holdings Inc.

Provide P/S
for Zimmer Biomet Holdings Inc.

Provide P/E
for Zimmer Biomet Holdings Inc.

Provide P/OCF
for Zimmer Biomet Holdings Inc.

Provide P/FCFE
for Zimmer Biomet Holdings Inc.

Provide P/B
for Zimmer Biomet Holdings Inc.

Provide EV/S
for Zimmer Biomet Holdings Inc.

Provide EV/GP
for Zimmer Biomet Holdings Inc.

Provide EV/EBITDA
for Zimmer Biomet Holdings Inc.

Provide EV/EBIT
for Zimmer Biomet Holdings Inc.

Provide EV/OCF
for Zimmer Biomet Holdings Inc.

Provide EV/FCFF
for Zimmer Biomet Holdings Inc.

Provide EV/IC
for Zimmer Biomet Holdings Inc.

Show me price targets
for Zimmer Biomet Holdings Inc made by professional analysts.

What are the Revenue projections
for Zimmer Biomet Holdings Inc?

How accurate were the past Revenue estimates
for Zimmer Biomet Holdings Inc?

What are the Net Income projections
for Zimmer Biomet Holdings Inc?

How accurate were the past Net Income estimates
for Zimmer Biomet Holdings Inc?

What are the EPS projections
for Zimmer Biomet Holdings Inc?

How accurate were the past EPS estimates
for Zimmer Biomet Holdings Inc?

What are the EBIT projections
for Zimmer Biomet Holdings Inc?

How accurate were the past EBIT estimates
for Zimmer Biomet Holdings Inc?

Compare the revenue forecasts
for Zimmer Biomet Holdings Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Zimmer Biomet Holdings Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Zimmer Biomet Holdings Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Zimmer Biomet Holdings Inc compared to its peers.

Compare the P/E ratios
of Zimmer Biomet Holdings Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Zimmer Biomet Holdings Inc with its peers.

Analyze the financial leverage
of Zimmer Biomet Holdings Inc compared to its main competitors.

Show all profitability ratios
for Zimmer Biomet Holdings Inc.

Provide ROE
for Zimmer Biomet Holdings Inc.

Provide ROA
for Zimmer Biomet Holdings Inc.

Provide ROIC
for Zimmer Biomet Holdings Inc.

Provide ROCE
for Zimmer Biomet Holdings Inc.

Provide Gross Margin
for Zimmer Biomet Holdings Inc.

Provide Operating Margin
for Zimmer Biomet Holdings Inc.

Provide Net Margin
for Zimmer Biomet Holdings Inc.

Provide FCF Margin
for Zimmer Biomet Holdings Inc.

Show all solvency ratios
for Zimmer Biomet Holdings Inc.

Provide D/E Ratio
for Zimmer Biomet Holdings Inc.

Provide D/A Ratio
for Zimmer Biomet Holdings Inc.

Provide Interest Coverage Ratio
for Zimmer Biomet Holdings Inc.

Provide Altman Z-Score Ratio
for Zimmer Biomet Holdings Inc.

Provide Quick Ratio
for Zimmer Biomet Holdings Inc.

Provide Current Ratio
for Zimmer Biomet Holdings Inc.

Provide Cash Ratio
for Zimmer Biomet Holdings Inc.

What is the historical Revenue growth
over the last 5 years for Zimmer Biomet Holdings Inc?

What is the historical Net Income growth
over the last 5 years for Zimmer Biomet Holdings Inc?

What is the current Free Cash Flow
of Zimmer Biomet Holdings Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Zimmer Biomet Holdings Inc.

Business Breakdown

Zimmer Biomet Holdings Inc. is a leading global medical device company renowned for its innovative solutions in the musculoskeletal health sector. Founded in 1927 and headquartered in Warsaw, Indiana, the company specializes in orthopedic implants, including those used in joint reconstruction and spinal surgery, as well as dental and neuromuscular devices. With a commitment to enhancing the quality of life for patients worldwide, Zimmer Biomet leverages cutting-edge technology and extensive research to develop products that cater to an aging population and a growing demand for minimally invasive surgical options. As the healthcare landscape evolves, Zimmer Biomet’s adaptable business strateg...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zimmer Biomet Holdings Inc

Current Assets 4.9B
Cash & Short-Term Investments 569m
Receivables 1.5B
Other Current Assets 2.8B
Non-Current Assets 16.9B
PP&E 2.1B
Intangibles 13.6B
Other Non-Current Assets 1.2B
Current Liabilities 3.6B
Accounts Payable 322.4m
Other Current Liabilities 3.2B
Non-Current Liabilities 5.8B
Long-Term Debt 4.7B
Other Non-Current Liabilities 1B
Efficiency

Earnings Waterfall
Zimmer Biomet Holdings Inc

Revenue
7.6B USD
Cost of Revenue
-2.1B USD
Gross Profit
5.5B USD
Operating Expenses
-3.9B USD
Operating Income
1.6B USD
Other Expenses
-468.1m USD
Net Income
1.1B USD

Free Cash Flow Analysis
Zimmer Biomet Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q3, Zimmer Biomet achieved 4% sales growth, marking 11 consecutive quarters of mid-single-digit growth. Despite ERP challenges affecting shipments, the impact is now estimated at 60-80 basis points, down from 100. The company expects 2024 revenue growth of 3.5%-4% due to currency fluctuations and a pricing outlook ranging from flat to +50 basis points. Adjusted earnings per share for 2024 is forecasted between $7.95 and $8.05, reflecting strong operational margins around 26.3%. With 50 significant product launches ahead, Zimmer Biomet is poised for sustainable growth, particularly across its Hips and S.E.T. segments.

What is Earnings Call?
Fundamental Scores

ZBH Profitability Score
Profitability Due Diligence

Zimmer Biomet Holdings Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive Revenue Growth Forecast
54/100
Profitability
Score

Zimmer Biomet Holdings Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

ZBH Solvency Score
Solvency Due Diligence

Zimmer Biomet Holdings Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
53/100
Solvency
Score

Zimmer Biomet Holdings Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ZBH Price Targets Summary
Zimmer Biomet Holdings Inc

Wall Street analysts forecast ZBH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZBH is 125.78 USD with a low forecast of 108.07 USD and a high forecast of 152.25 USD.

Lowest
Price Target
108.07 USD
0% Downside
Average
Price Target
125.78 USD
16% Upside
Highest
Price Target
152.25 USD
40% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ZBH?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ZBH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ZBH Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

ZBH News

Other Videos

Profile

Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc

Country

United States of America

Industry

Health Care

Market Cap

21.6B USD

Dividend Yield

0.89%

Description

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The company is headquartered in Warsaw Indiana, Indiana and currently employs 19,500 full-time employees. The company went IPO on 2001-07-25. The firm is engaged in the design, manufacture and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, craniomaxillofacial and thoracic (CMFT) products; dental implants, and related surgical products. The firm's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The company operates through four segments: Americas Orthopedics, Europe, Middle East and Africa (EMEA), Asia Pacific, and Americas Spine and Global Dental. Its knee brands include Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. Its S.E.T. brands include JuggerKnot Soft Anchor System, Gel-One1 Cross-linked Hyaluronate, Comprehensive Shoulder and others.

Contact

INDIANA
Warsaw Indiana
345 E Main St
+15742676131.0
www.zimmerbiomet.com

IPO

2001-07-25

Employees

19 500

Officers

COO, President, CEO & Director
Mr. Ivan Tornos
CFO and Executive VP of Finance, Operations & Supply Chain
Mr. Suketu P. Upadhyay
Senior VP, General Counsel & Secretary
Mr. Chad F. Phipps
President of Asia Pacific
Mr. Sang Yi
Group President of Europe, Middle East & Africa
Mr. Wilfred van Zuilen
VP, Controller & Chief Accounting Officer
Mr. Paul A. Stellato
Show More
Senior VP & Chief Information and Technology Officer
Mr. Shaun Braun
Senior VP & Chief Administrative Officer
Ms. Rachel H. Ellingson
Senior VP of Investor Relations
Mr. David M. DeMartino
Senior VP, Global Chief Compliance Officer & Associate General Counsel of Asia Pacific
Ms. Angela Main
Show Less

See Also

Discover More
What is the Intrinsic Value of one ZBH stock?

The intrinsic value of one ZBH stock under the Base Case scenario is 152.24 USD.

Is ZBH stock undervalued or overvalued?

Compared to the current market price of 108.41 USD, Zimmer Biomet Holdings Inc is Undervalued by 29%.

Back to Top